# NIH Reporter #5F31CA294869-02

Investigating the role of tumor-intrinsic BCAT1 in HCC growth and anti-tumor immunity

**Recipient:** University of Pennsylvania

**Award Amount:** $50,114.00
**Ceiling:** $50,114.00

**Awarded:** July 06, 2026

**Identifier:** 5F31CA294869-02

The National Cancer Institute awarded the University of Pennsylvania funding for research on the role of BCAT1 in hepatocellular carcinoma growth and tumor immunity.

### Description

Project investigating whether BCAT1 promotes hepatocellular carcinoma growth and suppresses anti-tumor immunity by reducing branched-chain amino acid availability to immune cells. The work includes in vitro and in vivo studies of BCAT1 knockdown, tumor growth, and immune cell populations.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11369519)
